WIF1 and breast carcinoma: WNT inhibitory factor 1, WIF1, was downregulated in P women, and although methylation of WIF1 has been observed in several tumors [39], including breast cancer [40], this can be an indication that the WNT pathway has an important role in the shifting of the stem cells to a more differentiated status in the P breast, as demonstrated earlier [8, 41].